Article
SerpinB3 drives cancer stem cell survival in glioblastoma
1 Sept 2022
Abstract excerpt
Despite therapeutic interventions for glioblastoma (GBM), cancer stem cells (CSCs) drive recurrence. The precise mechanisms underlying CSC resistance, namely inhibition of cell death, are unclear. We built on previous observations that the high cell surface expression of junctional adhesion molecule-A drives CSC maintenance and identified downstream signaling networks, including the cysteine protease inhibitor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
